Patterns of Infection in Patients With Myelodysplastic Syndromes and Acute Myeloid Leukemia Receiving Azacitidine as Salvage Therapy. Implications for Primary Antifungal Prophylaxis

The National Comprehensive Cancer Network

William T. McGivney · Cancer · 1998 · 16.9K citations

Medicine, Oncology, Clinical Informatics +15

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

Ben de Pauw, Thomas J. Walsh, J. Peter Donnelly et al. · Clinical Infectious Diseases · 2008 · 4.9K citations · Full text

Veterinary Medicine, Infectious Diseases, Oncology +7

Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America

Alison G. Freifeld, Eric J. Bow, Kent A. Sepkowitz et al. · Clinical Infectious Diseases · 2011 · 3.4K citations

Pharmacy, Infectious Diseases, Oncology +17

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

Pierre Fenaux, Ghulam J. Mufti, Eva Hellström‐Lindberg et al. · The Lancet Oncology · 2009 · 2.6K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia

Oliver A. Cornely, Johan Maertens, Drew J. Winston et al. · New England Journal of Medicine · 2007 · 1.8K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12